Emtriva (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Emtriva drug offered from Gilead Sciences, Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
| NON-PROPRIETARY NAME: | EMTRICITABINE |
| SUBSTANCE NAME: | EMTRICITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-09-28 |
| END MARKETING DATE: | 0000-00-00 |
Emtriva HUMAN PRESCRIPTION DRUG Details:
| Item Description | Emtriva from Gilead Sciences, Inc. |
| LABELER NAME: | Gilead Sciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2005-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-0602_9d004165-8e41-4b34-97e5-fca88062969c |
| PRODUCT NDC: | 61958-0602 |
| APPLICATION NUMBER: | NDA021896 |
Other EMTRICITABINE Pharmaceutical Manufacturers / Labelers:
